Mic Iwashima

Prior to joining Satsuma Pharmaceuticals, Mic served since 2002 in a variety of management roles at Shin Nippon Biomedical Laboratories.  Mic has an extensive background in nasal drug delivery, with 15 years of experience developing SNBL’s nasal drug delivery platform technology and product candidates.  His roles at SNBL have encompassed operations, product development, regulatory affairs, business development and intellectual property management.  Mic earned an engineering degree from North Carolina State University, where he also did research in the area of nasal flow computational fluid dynamics.